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Vignesh Ramchandran1, Thomas O’Hara1, Yogananda S. Markandeya2,
Ravi C. Balijepalli2, Timothy J. Kamp2, Natalia A. Trayanova1.
1Johns Hopkins University, Baltimore, MD, USA, 2University of Wisconsin,
Madison, WI, USA.
Caveolin proteins are involved in establishing membrane microstructure, lipid
raft organization, and cell signaling. In the heart, caveolin-3 (Cav3) predomi-
nates. Inherited or disease-induced Cav3 loss increases risk of sudden cardiac
death (SCD). We aimed to explore connections between Cav3 loss and arrhyth-
mogenic changes in the ventricular action potential (AP) by investigating the
Cav3 dependence of ionic currents. Drugs commonly used to disrupt or remove
Cav3 in cultured cells exclude any compensatory process likely to occur in
vivo. This motivated us to engineer a novel conditional Cav3 knockout
(Cav3-/-) mouse that survives to adulthood. We isolated ventricular cells for
electrophysiological experimentation.
AP duration (APD90) was prolonged from 2454 ms in WT to 9659 ms in
Cav3-/-, and several currents were affected. Reduced peak: L-type Ca2þ current
(ICaL), 21%; slow Kþ current, 81%; transient outward Kþ current, 57%; steady
state outward Kþ current (Iss), 43%. Late Naþ current was enhanced ~10-fold.
These changes were partially offsetting - preventing a simple account for the
APD90 increase. To relate changes in currents to changes in the AP, we devel-
oped a computational representation of Cav3-/- based on the Morotti et al.
mouse ventricular cell model and defined by fractional change in currents.
Unexpectedly, the relatively small change in relatively small Iss caused 33% of
total simulated AP prolongation. Though Iss conductance was reduced, peak Iss
actually increased in the dynamic setting of the simulated AP. Early in the AP,
lower Iss indirectly enhanced inward currents (importantly late ICaL) by extend-
ing the plateau phase, which in turn allowed Iss to more fully activate. This Iss/
ICaL process largely accounted for the pro-arrhythmic APD90 increase
followingCav3 loss and is therefore a candidate target for normalizing SCD risk.
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Diabetes mellitus is associated with sinoatrial node dysfunction, as evidenced
by an increased risk of atrial fibrillation, pacemaker implantation due to brady-
cardia and cardiac death in diabetic patients. While sinoatrial node myocytes
(SAMs) generate the spontaneous action potentials (APs) that initiate each
heartbeat, little is known about how diabetes affects SAMs directly. In this
study, we used streptozoticin (STZ) -treated mice as a model of diabetic hyper-
glycemia. Four weeks after STZ injections, we found that both intrinsic heart
rate (measured during autonomic blockade) and maximum heart rate (measured
during restraint stress) were reduced in diabetic animals compared to pre-
treatment values. Current-clamp recordings from acutely isolated SAMs from
diabetic animals revealed corresponding reductions in spontaneous AP firing
rates. AP waveform analysis showed that the reduced firing rates in diabetic
cells resulted from a prolongation of the AP duration and a slowing of the
rate of repolarization. Accordingly, we observed significant decreases in steady
state and transient outward Kþ current densities in whole-cell voltage-clamp
recordings from SAMs from diabetic animals. Diabetes caused little or no
change in voltage-gated calcium currents in diabetic SAMs. The effects of dia-
betes on the AP waveform and firing rate were mimicked by application of
10 mM 4-aminopyridine in current clamp experiments and when the transient
outward Kþ current was reduced in a mathematical model of the sinoatrial
AP. These results suggest that diabetic sinoatrial node dysfunction results in
part from electrical remodeling of Kþ currents in sinoatrial node myocytes,
which paradoxically slows the spontaneous AP firing rate and thus heart rate.
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Madison, WI, USA.Cardiac L-type Ca2þ channels (LTCC) play essential role in multiple cellular
processes including excitation-contraction coupling, signaling and gene regula-
tion. Diverse families of regulatory and scaffolding proteins regulate the
LTCCs in the cardiomyocytes. Leucine-rich repeat containing 10 (LRRC10)
is a cardiac-specific scaffolding protein that plays a critical role in heart devel-
opment and function. Recently we have demonstrated that the Lrrc10-null
(Lrrc10-/-) mice develop dilated cardiomyopathy and Lrrc10-/- cardiomyocytes
exhibit reduced LTCC current (ICa,L). However, it is unclear how LRRC10 reg-
ulates LTCC function in the heart. To investigate the role of LRRC10 in the
regulation of LTCCs, we co-expressed the WT LRRC10 with LTCC channel
complex comprising of the Cav1.2, b2CN2, a2d subunits in HEK293 cells and
performed whole-cell patch clamp experiments. Co-expression of LRRC10
significantly enhanced (225%) the peak LTCC current (IBa,L 7557 pA/pF)
density compared to LTCC alone (3353 pA/pF).We then introduced a single
point mutation (substituted alanine for histidine) in the putative functional
interaction site at amino acid position 150 (H150A) of LRRC10. Co-
expression of LRRC10H150A caused significant reduction (27%) in IBa,L
(-5754 pA/pF) compared to WT LRRC10 co-expression. Furthermore,
G/Gmax analysis revealed a significant shift in the voltage dependence of acti-
vation to more negative potentials with the co-expression of either the WT
LRRC10 (V1/2,-21.7mV) or the H150A mutation (V1/2, 25.1mV) compared
to LTCC alone (V1/2,16.4mV). Finally, co-immunoprecipitation and western
blot analysis in HEK293 cells demonstrated that LRRC10 associates with
Cav1.2 subunit but not the Cav2 subunit. Moreover, co-expression of the
LRRC10 H150A mutation disrupted the association of Cav1.2 with LRRC10.
We conclude that LRRC10 may directly associate with Cav1.2 subunit and
regulate the LTCC function by enhancing the surface expression, density and
biophysical properties of the ICa,L.
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Both CaMKII and PKA contribute to fight or flight heart rate (HR) increases in
response to isoproterenol or activity. CaMKII and PKA promote HR increases,
at least in part, by actions on ‘Ca2þ clock’ homeostatic proteins. The Ca2þ
clock mechanism for cardiac pacing relies on SR proteins governing SR
Ca2þ uptake and release. Inhibition of SR Ca2þ release by ryanodine slows
HR but we are unaware of any studies testing the potential for slowing SR
Ca2þ uptake to reduce HR. Phospholamban (PLN) is a negative regulator of
SERCA that acts to slow SR Ca2þ uptake. PLN phosphorylation is catalyzed
by PKA, at serine 16, or CaMKII, at threonine 17. PKA and CaMKII can
also promote SR Ca2þ release by catalyzing phosphorylation of the ryanodine
receptor (RyR2). CaMKII phosphorylation at Ser 2814 and PKA phosphoryla-
tion at Ser 2808 can increase RyR2 Ca2þ leak that drives cell membrane depo-
larizing inward current through the Naþ/Ca2þ exchanger. Despite the mounting
evidence that CaMKII and PKA sites on PLN and RyR2 are important for car-
diac pacing, the relative importance of these sites is unknown and the potential
for any particular site to exert a controlling influence over fight or flight phys-
iology is untested. Here we have taken advantage of genetically modified
mouse models where CaMKII and PKA sites are specifically ablated to inter-
rogate the role of each site and determine if any of these SR protein sites exer-
cises a decisive influence on HR responses to isoproterenol or activity. The
results from genetically modified mice harboring various PLN mutantions
(PLN-/-, N27A, S16A, T17A) and RYR2 mutations (S2808A and S2814A)
suggest that established CaMKII and PKA sites do not, by themselves, control
fight or flight HR responses.
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Background: We have previously shown that non-equilibrium reactivation of
the Na current (INa) drives Isoproterenol-induced phase-3 early afterdepolariza-
tions (EADs) in failing mouse ventricular myocytes. EAD initiation is
